Seraxis Takes Its Islet Cell Tech Into The Clinic

Emerging Company Profile: The Maryland-based biotech is working on a functional cure for type 1 diabetes that is similar to Vertex’s VX-880 – but with some key differences.

Embryonic stem cells , Cellular therapy , Regeneration , Disease treatment , 3d illustration - Illustration
Stem cells

More from Emerging Company Profiles

More from Therapy Areas